|Bid||2.1200 x 21500|
|Ask||2.1300 x 4000|
|Day's Range||2.0800 - 2.2700|
|52 Week Range||1.5000 - 5.7700|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar. 30, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||5.50|
Weekly Roundup on the Cannabis Sector & Psychedelic Sector Key Takeaways; Cannabis Sector Marijuana multistate operator Jushi to acquire Nevada’s NuLeaf in a deal worth $62.5 million. Village Farms buys Quebec cannabis producer for CA$46.7 million. Schwazze acquires a Colorado marijuana store for $4 million and stock; and spends $29 million to acquire two more […] The post Weekly Roundup on the Cannabis Sector & Psychedelic Sector appeared first on Market Exclusive.
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD; NEO: MMED; DE: MMQ; the "Company"), a leading biotech company developing psychedelic-inspired therapies, is pleased to announce it has launched recruitment for a randomized placebo-controlled study evaluating the effects of daytime and evening administration of repeated low doses of LSD (the "LSD Study").
MindMed (Nasdaq: MNMD, NEO: MMED, DE: MMQ), a leading biotech company developing psychedelic-inspired therapies, has announced its quarterly financial results for the quarter ended September 30, 2021.